Genetic Alliance is collaborating with the EspeRare Foundation of Geneva, Switzerland, to streamline the process of translating research into health outcomes. Together, we will strengthen decision-making in drug development.
Assessing the potential for drug development in different disease areas, particularly for rare and neglected diseases, is a complex and nuanced process. Today, without any open-source tool, these efforts are largely scattered and conducted in silos by different stakeholders. GaugeRx will fill this gap as an interactive, web-based analytics and assessment tool that integrates and translates the vast amount of knowledge about human health and disease to support drug repositioning and development decision-making for a broad range of healthcare stakeholders, from pharmaceutical companies to advocacy organizations. GaugeRx especially aims to assist advocacy organizations in strengthening the drug development ecosystem of a disease.